USFDA declines to approve this Urinary Tract Infection Drug

But the company suffered a setback in March when the agency found certain deficiencies in the drug's marketing application.

335
Medicine red round tablets making sign of cross reject, refuse, decline, denied, No
Picture: Pixabay

Last Updated on December 31, 2023 by The Health Master

New York: The U.S. Food and Drug Administration (USFDA) declined to approve Spero Therapeutics Inc’s oral antibiotic drug for the treatment of patients with complicated urinary tract infections (UTI), the company said on Monday.

In the complete response letter, the health regulator concluded that Spero’s late-stage study testing the drug was insufficient and an additional study would be required, the drugmaker said.

Shares of Spero fell about 14% after the bell.

Spero had sought approval for its most advanced drug candidate, tebipenem, to treat the infections, including a type of kidney inflammation called pyelonephritis in adult patients with limited oral treatment options.

But the company suffered a setback in March when the agency found certain deficiencies in the drug’s marketing application.

Spero later suspended commercialization activities for tebipenem and slashed its workforce by about 75%, as the USFDA’s feedback suggested that the data on the drug could be insufficient to obtain approval.

The drugmaker said on Monday it intends to promptly request a meeting with the health regulator.

USFDA declines to approve this Anti-seizure drug

USFDA declines to authorise this viral skin disease treatment

USFDA declines pediatric EUA for vaccine Covaxin

USFDA declines to approve Gilead’s HIV drug on this concern

USFDA declines to approve GSK’s HIV inj.

FDA warning against self-medication

IPA calls Nutraceutical, Pharma industries to join hands to provide holistic care

PCI planning to help pharmacists fight e-Pharmacies

Govt to monitor sale of these 11 Drugs from being misused

Medical Stores to keep records of C-19 Self-test kit buyers

USFDA approves Pneumococcal Vaccine for children

Drug Alert: NSQ Drugs Lists

USFDA approves Pneumococcal Vaccine for children

Data security a priority for Pharma Companies in India

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news